Prevention of cardiovascular disease in type 1 diabetes
Manrique-Acevedo C, Hirsch I.B, Eckel R.H
N Engl J Med. Pub. Online 3 Apr 2024.
Leggi
Breaking news
Association between treatment adherence and continuous glucose monitoring outcomes in people with diabetes using smart insulin pens in a real-world setting
Danne T, Joubert M, Hartvig NV, et al.
Diabetes Care. Pub. Online 3 Apr 2024.
Leggi
Recommendations for management of diabetes and its complications during Hajj (Muslim Pilgrimage) – 2024 update
Ibrahim M, Ba-Essa E, Alarouj M, et al.
Diabetes Res Clin Pract. Pub. online 1 Apr 2024.
Leggi
Metabolic profile and long-term risk of depression, anxiety, and stress-related disorders
Chourpiliadis C, Zeng Y, Lovik A, et al.
JAMA Netw Open. Pub. Online 1 Apr 2024.
Leggi
Threshold of hyperglycaemia associated with mortality in critically ill patients: a multicentre, prospective, observational study using continuous glucose monitoring
Wang Y, Li S, Lu J, et al.
Diabetologia. Pub. Online 3 Apr 2024.
Leggi
Empagliflozin after acute myocardial infarction
Butler J, Jones WS, Udell JA, et al.
N Engl J Med. Pub. Online 6 Apr 2024.
Leggi
Trial of lixisenatide in early Parkinson’s disease
Meissner WG, Remy P, Giordana C, et al.
N Engl J Med. Pub. Online 3 Apr 2024.
Leggi
Semaglutide in patients with obesity-related heart failure and type 2 diabetes
Kosiborod MN, Petrie MC, Borlaug BA, et al.
N Engl J Med. Pub. Online 6 Apr 2024.
Leggi
Effect of testosterone on progression from prediabetes to diabetes in men with hypogonadism: A substudy of the TRAVERSE randomized clinical trial
Bhasin S, Lincoff AM, Nissen SE, et al.
JAMA Intern Med. 2024;184(4):353-362.
Leggi
Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: Insights from the EMPACT-MI trial
Hernandez AF, Udell JA, Jones WS, et al.
Circulation. Pub. Online 6 Apr 2024.
Leggi